PCI of antibody based therapeutics

Current therapeutic use of antibodies is limited to antigens expressed on the cell surface or released into the circulation due to a lack of an effective mechanisms to access the inside of the cell. 

In this project we aim to use the PCI method to obtain efficient cytosolic/nuclear delivery of antibodies having intracellular targets.

 

The project is founded by Radforsk with a 3 years fellowship provided Weyergang

 
Page visits: 820